Atika Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,000
| Closed | -$805K | – | 76 |
|
|
2025
Q1 | $805K | Sell |
24,000
-48,600
| -67% | -$1.63M | 0.11% | 52 |
|
|
2024
Q4 | $2.85M | Sell |
72,600
-53,400
| -42% | -$2.09M | 0.3% | 69 |
|
|
2024
Q3 | $4.96M | Buy |
126,000
+2,000
| +2% | +$78.7K | 0.51% | 57 |
|
|
2024
Q2 | $4.83M | Buy |
124,000
+2,000
| +2% | +$78K | 0.47% | 58 |
|
|
2024
Q1 | $5.25M | Buy |
122,000
+28,766
| +31% | +$1.24M | 0.52% | 60 |
|
|
2023
Q4 | $4.29M | Buy |
+93,234
| New | +$4.29M | 0.58% | 57 |
|
|
2023
Q3 | – | Sell |
-68,050
| Closed | -$2.62M | – | 98 |
|
|
2023
Q2 | $2.62M | Buy |
68,050
+600
| +0.9% | +$23.1K | 0.26% | 65 |
|
|
2023
Q1 | $2.41M | Buy |
+67,450
| New | +$2.41M | 0.36% | 61 |
|